Skip to content
Article Rich – Lifestyle
Author:
Ceruvia Lifesciences
Ceruvia Strengthens Intellectual Property Position for BOL-148 with Three U.S. Patent Allowances and Unitary Patent Grant in Europe
August 27, 2026
Ceruvia Raises $8 Million to Complete Integrated Phase 1/2 Trial of Proprietary Non-Hallucinogenic LSD Analog for Cluster Headache
August 3, 2026